Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aspira Pathlab & Diagnostics has notified BSE about its 52nd Annual General Meeting (AGM) scheduled for Friday, September 26, 2025 at 2:00 PM, to be held via video conferencing. The filing includes the AGM Notice and the Annual Report for FY 2024-25. The key business items to be transacted are: (1) adoption of audited standalone and consolidated financial statements for the year ended March 31, 2025; (2) re-appointment of Executive Director Mr. Nikunj V Mange, who retires by rotation; (3) appointment of M/s. Nilesh A. Pradhan & Co., LLP as Secretarial Auditors for a five-year term from April 1, 2025 to March 31, 2030; and (4) appointment of Dr. Alaka Keshav Deshpande as an Independent Director for three years. The record date for eligibility to attend and vote is September 19, 2025, with e-voting open from September 23 to September 25, 2025.
This is a routine regulatory filing (Regulation 34 of SEBI LODR) sharing the AGM Notice and Annual Report — it carries no immediate price impact. Shareholders should review the financials and director appointments ahead of the September 26 meeting and voting window.